Man Chun John

1.8k total citations
19 papers, 285 citations indexed

About

Man Chun John is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Man Chun John has authored 19 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Man Chun John's work include Lymphoma Diagnosis and Treatment (5 papers), Immune Cell Function and Interaction (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Man Chun John is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Immune Cell Function and Interaction (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Man Chun John collaborates with scholars based in United States, China and United Kingdom. Man Chun John's co-authors include R. Eric Davis, Jason R. Westin, Zhiqiang Wang, Wencai Ma, Nathan Fowler, Felipe Samaniego, Shouhao Zhou, Sattva S. Neelapu, Lei Feng and Anne E. Kwitek and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Man Chun John

17 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Man Chun John United States 10 146 116 103 69 58 19 285
Maciej Szydłowski Poland 9 102 0.7× 104 0.9× 151 1.5× 81 1.2× 37 0.6× 34 313
Chi Wai Wong Hong Kong 7 130 0.9× 96 0.8× 303 2.9× 55 0.8× 48 0.8× 12 447
Gloria E. Marino Italy 8 160 1.1× 46 0.4× 119 1.2× 61 0.9× 30 0.5× 18 322
Filippo Severin Italy 12 54 0.4× 74 0.6× 132 1.3× 99 1.4× 159 2.7× 20 298
Kristin E. Hunt United States 7 101 0.7× 150 1.3× 240 2.3× 23 0.3× 52 0.9× 11 428
Gedeon Loules Greece 11 92 0.6× 49 0.4× 82 0.8× 164 2.4× 123 2.1× 14 383
Billy Michael Chelliah Jebaraj Germany 10 49 0.3× 99 0.9× 117 1.1× 75 1.1× 173 3.0× 19 300
Sandra Gallagher United States 9 54 0.4× 67 0.6× 72 0.7× 107 1.6× 36 0.6× 11 312
Melanie Sulda Australia 7 76 0.5× 51 0.4× 185 1.8× 49 0.7× 81 1.4× 12 315
M Siena Italy 9 101 0.7× 41 0.4× 162 1.6× 142 2.1× 35 0.6× 11 400

Countries citing papers authored by Man Chun John

Since Specialization
Citations

This map shows the geographic impact of Man Chun John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Chun John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Chun John more than expected).

Fields of papers citing papers by Man Chun John

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man Chun John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Chun John. The network helps show where Man Chun John may publish in the future.

Co-authorship network of co-authors of Man Chun John

This figure shows the co-authorship network connecting the top 25 collaborators of Man Chun John. A scholar is included among the top collaborators of Man Chun John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Man Chun John. Man Chun John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
John, Man Chun, Patricia Kraft, Tom G. Mayer, et al.. (2025). Sodium–Glucose Cotransporter-2 Inhibitor Canagliflozin Improves Vascular Graft Function in a Rat Bypass Model. The Thoracic and Cardiovascular Surgeon. 73.
2.
Nastoupil, Loretta J., Jason R. Westin, Nathan Fowler, et al.. (2022). Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma. Blood Advances. 6(4). 1143–1151. 29 indexed citations
3.
Nishida, Yuki, Ran Zhao, Lauren Heese, et al.. (2021). Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML. Leukemia. 35(9). 2469–2481. 25 indexed citations
4.
Henderson, Jared, Ondřej Havránek, Man Chun John, et al.. (2021). Detecting Förster resonance energy transfer in living cells by conventional and spectral flow cytometry. Cytometry Part A. 101(10). 818–834. 8 indexed citations
5.
Ishizawa, Jo, Kenji Nakamaru, Takahiko Seki, et al.. (2018). Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition. Cancer Research. 78(10). 2721–2731. 44 indexed citations
6.
Weng, Jinsheng, Yong Pan, Man Chun John, et al.. (2018). Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas. Blood. 132(Supplement 1). 3488–3488. 1 indexed citations
7.
Nastoupil, Loretta J., Jason R. Westin, Nathan Fowler, et al.. (2017). High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study. Blood. 130. 414–414. 14 indexed citations
8.
Manasanch, Elisabet E., Rohit Mathur, Hans C. Lee, et al.. (2017). Pilot Study of Pembrolizumab for Immunoprevention in Smoldering Multiple Myeloma. Blood. 130. 3089–3089. 3 indexed citations
9.
Martín‐Gálvez, David, et al.. (2017). Genome variation and conserved regulation identify genomic regions responsible for strain specific phenotypes in rat. BMC Genomics. 18(1). 986–986. 2 indexed citations
10.
John, Man Chun, et al.. (2017). Contribution of independent and pleiotropic genetic effects in the metabolic syndrome in a hypertensive rat. PLoS ONE. 12(8). e0182650–e0182650. 9 indexed citations
11.
John, Man Chun, et al.. (2017). Furosemide for prevention of cyclophosphamide‐associated sterile haemorrhagic cystitis in dogs receiving metronomic low‐dose oral cyclophosphamide. Veterinary and Comparative Oncology. 15(4). 1468–1478. 10 indexed citations
12.
Zhang, Qi, Lina Han, Rongqing Pan, et al.. (2017). MCL-1 Up-Regulation through MAPK Activation Confers Acquired Resistance to BCL-2 Inhibitor ABT-199 in Pre-Clinical AML Models. Clinical Lymphoma Myeloma & Leukemia. 17(10). S2–S2.
13.
Westin, Jason R., Nathan Fowler, Michelle A. Fanale, et al.. (2017). HIGH RESPONSE RATES WITH PEMBROLIZUMAB IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: INTERIM RESULTS OF AN ON OPEN‐LABEL, PHASE II STUDY. Hematological Oncology. 35(S2). 120–121. 9 indexed citations
14.
Havránek, Ondřej, Jingda Xu, Stefan Köhrer, et al.. (2017). Tonic B-cell receptor signaling in diffuse large B-cell lymphoma. Blood. 130(8). 995–1006. 66 indexed citations
15.
Nastoupil, Loretta J., Jason R. Westin, Nathan Fowler, et al.. (2017). Response rates with pembrolizumab in combination with rituximab in patients with relapsed follicular lymphoma: Interim results of an on open-label, phase II study.. Journal of Clinical Oncology. 35(15_suppl). 7519–7519. 33 indexed citations
16.
Zhāng, Qí, Lina Han, Ce Shi, et al.. (2016). Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML. Blood. 128(22). 101–101. 5 indexed citations
17.
Wang, Jinkai, Man Chun John, Janette Pettus, et al.. (2015). Systems Biology With High-Throughput Sequencing Reveals Genetic Mechanisms Underlying the Metabolic Syndrome in the Lyon Hypertensive Rat. Circulation Cardiovascular Genetics. 8(2). 316–326. 17 indexed citations
18.
John, Man Chun, Santosh S. Atanur, Timothy J. Aitman, & Anne E. Kwitek. (2014). Genomic structure of nucleotide diversity among Lyon rat models of metabolic syndrome. BMC Genomics. 15(1). 197–197. 7 indexed citations
19.
John, Man Chun, et al.. (1997). Effect of jiawei shenqi dihuang tang on the content of urinary protein in patients with diabetic nephropathy.. PubMed. 17(3). 184–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maciej Szydłowski Breakdown of academic impact, for papers by Chi Wai Wong Breakdown of academic impact, for papers by Gloria E. Marino Breakdown of academic impact, for papers by Filippo Severin Breakdown of academic impact, for papers by Kristin E. Hunt Breakdown of academic impact, for papers by Gedeon Loules Breakdown of academic impact, for papers by Billy Michael Chelliah Jebaraj Breakdown of academic impact, for papers by Sandra Gallagher Breakdown of academic impact, for papers by Melanie Sulda Breakdown of academic impact, for papers by M Siena
Rankless by CCL
2026